179 related articles for article (PubMed ID: 36835048)
1. The Expression of Autophagy-Associated Genes Represents a Valid Footprint for Aggressive Pancreatic Neuroendocrine Neoplasms.
Matrood S; Melms LE; Bartsch DK; Di Fazio P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835048
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death.
Matrood S; de Prisco N; Wissniowski TT; Wiese D; Jabari S; Griesmann H; Wanzel M; Stiewe T; Neureiter D; Klieser E; Mintziras I; Buchholz M; Bartsch DK; Gennarino VA; Di Fazio P
Neuroendocrinology; 2021; 111(10):965-985. PubMed ID: 33108790
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.
Yang Y; Yang L; Li Y
Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046
[TBL] [Abstract][Full Text] [Related]
4. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
[TBL] [Abstract][Full Text] [Related]
5. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
[TBL] [Abstract][Full Text] [Related]
7. Global microRNA profiling of pancreatic neuroendocrine neoplasias.
Thorns C; Schurmann C; Gebauer N; Wallaschofski H; Kümpers C; Bernard V; Feller AC; Keck T; Habermann JK; Begum N; Lehnert H; Brabant G
Anticancer Res; 2014 May; 34(5):2249-54. PubMed ID: 24778027
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers.
Abdalla TSA; Klinkhammer-Schalke M; Zeissig SR; Tol KK; Honselmann KC; Braun R; Bolm L; Lapshyn H; Litkevych S; Zemskov S; Begum N; Kulemann B; Hummel R; Wellner UF; Keck T; Deichmann S
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8535-8543. PubMed ID: 37095413
[TBL] [Abstract][Full Text] [Related]
9. The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms.
He L; Boulant S; Stanifer M; Guo C; Nießen A; Chen M; Felix K; Bergmann F; Strobel O; Schimmack S
Cancer Sci; 2022 May; 113(5):1575-1586. PubMed ID: 35179814
[TBL] [Abstract][Full Text] [Related]
10. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
12. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
Goldin SB; Aston J; Wahi MM
Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1.
Sonoda A; Yamashita YI; Kondo T; Hayashi H; Imai K; Higashi T; Yamamura K; Yamao T; Hashimoto D; Baba H
J Hepatobiliary Pancreat Sci; 2020 Dec; 27(12):984-991. PubMed ID: 32278331
[TBL] [Abstract][Full Text] [Related]
14. [Controversy: asymptomatic small pancreatic neuroendocrine neoplasms : Current standards in diagnostics and treatment].
Wiese D; Bartsch DK
Chirurgie (Heidelb); 2022 Aug; 93(8):739-744. PubMed ID: 35913627
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing as a tool for searching for genetic background modifiers in MEN1 patients with neuroendocrine pancreatic tumours, including insulinomas.
Skalniak A; Trofimiuk-Müldner M; Jabrocka-Hybel A; Totoń-Żurańska J; Wołkow P; Hubalewska-Dydejczyk A
Endokrynol Pol; 2023; 74(1):31-46. PubMed ID: 36847722
[TBL] [Abstract][Full Text] [Related]
16. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
Ito T; Hijioka S; Masui T; Kasajima A; Nakamoto Y; Kobayashi N; Komoto I; Hijioka M; Lee L; Igarashi H; Jensen RT; Imamura M
J Gastroenterol; 2017 Jan; 52(1):9-18. PubMed ID: 27539256
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
Baur AD; Pavel M; Prasad V; Denecke T
Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
Tonelli F; Marini F; Giusti F; Iantomasi T; Giudici F; Brandi ML
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894286
[TBL] [Abstract][Full Text] [Related]
19. Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm.
Wu L; Zou T; Shi D; Cheng H; Shahbaz M; Umar M; Li T; Zhang X; Gong P; Wei Y
BMC Endocr Disord; 2022 Oct; 22(1):255. PubMed ID: 36271376
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms.
Schmitt AM; Pavel M; Rudolph T; Dawson H; Blank A; Komminoth P; Vassella E; Perren A
Neuroendocrinology; 2014; 100(1):35-44. PubMed ID: 25012122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
